Amesite (AMST) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for January 21, 2025, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and vote by January 20, 2025.
Voting matters and shareholder proposals
Election of two Class I director nominees: J. Michael Losh and Richard Ogawa.
Ratification of Turner, Stone & Company L.L.P. as independent registered public accountants for the fiscal year ending June 30, 2025.
Proxy holders may vote on other business that arises at the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of both director nominees and the auditor ratification.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Amesite
- NurseMagic™ app drives rapid revenue growth and market adoption in healthcare AI.AMST
Investor presentation6 Feb 2026 - NurseMagic's rapid adoption and scalable AI platform drive strong revenue and market growth.AMST
Investor presentation6 Feb 2026 - Revenue surged but losses persist; going concern and Nasdaq compliance risks remain.AMST
Q2 20266 Feb 2026 - Director and auditor approved; NurseMagic gains traction; strong insider investment.AMST
AGM 202510 Jan 2026 - NurseMagic's rapid adoption and scalable sales model position the company for profitable growth in 2025.AMST
Sidoti Micro-Cap Virtual Conference9 Jan 2026 - Flexible $100M shelf registration targets growth in AI-driven education and healthcare solutions.AMST
Registration Filing16 Dec 2025 - Shelf registration allows up to $100M in flexible offerings to fund AI-driven growth initiatives.AMST
Registration Filing16 Dec 2025 - Annual meeting to elect directors, ratify auditor, and reinforce governance and sustainability.AMST
Proxy Filing2 Dec 2025 - Director resignations reduce Class I nominees to one; votes for withdrawn nominee disregarded.AMST
Proxy Filing2 Dec 2025